We are live on ! Find out more
PBH icon

Prestige Consumer Healthcare

237 hedge funds and large institutions have $2.48B invested in Prestige Consumer Healthcare in 2018 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 79 increasing their positions, 95 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

5.45% more ownership

Funds ownership: 120.87%126.32% (+5.5%)

8% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 25

1% more capital invested

Capital invested by funds: $2.46B → $2.48B (+$14.8M)

0% more funds holding

Funds holding: 237237 (0)

17% less repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 95

61% less call options, than puts

Call options by funds: $2.63M | Put options by funds: $6.67M

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
237
Holders Change
Holders Change %
0%
% of All Funds
5.42%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
27
Increased
79
Reduced
95
Closed
25
Calls
$2.63M
Puts
$6.67M
Net Calls
-$4.04M
Net Calls Change
-$3.33M

PBH Hedge Fund Activity: Q3 2018 in Review

237 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q3 2018, worth a combined $2.48B — up 0.6% from $2.46B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new PBH positions and 25 closed out — a net gain of 2 holders — while 79 added to existing stakes and 95 trimmed.

The largest buyer was Dalton, Greiner, Hartman, Maher & Co, opening a new position worth an estimated $16.8M. The largest seller was Manor Road Capital Partners, cutting an estimated $35M.

  • 237 institutional investors held Prestige Consumer Healthcare (PBH) as of Q3 2018, unchanged from Q2 2018.
  • Funds reported $2.48B of Prestige Consumer Healthcare stock for Q3 2018, up 0.6% quarter-over-quarter.
  • 27 funds opened new Prestige Consumer Healthcare positions in Q3 2018 and 25 closed out, a net change of +2 holders.
  • The largest Prestige Consumer Healthcare buyer in Q3 2018 was Dalton, Greiner, Hartman, Maher & Co, an estimated $16.8M added.
  • The largest Prestige Consumer Healthcare seller in Q3 2018 was Manor Road Capital Partners, an estimated $35M sold.

Based on aggregated 13F filings for Q3 2018.